AEs occurring in 10% or more of patients, regardless of the study drug relationship
AEs, n (%) | Total (N = 47) | ||
---|---|---|---|
All grades | Grade 3 | Grade 4 | |
Any | 47 (100) | 29 (61.7) | 6 (12.8) |
Diarrhea | 36 (76.6) | 5 (10.6) | 0 |
Fatigue | 36 (76.6) | 12 (25.5) | 1 (2.1) |
Nausea | 36 (76.6) | 4 (8.5) | 0 |
Vomiting | 22 (46.8) | 2 (4.3) | 0 |
Weight decrease | 17 (36.2) | 0 | 0 |
Anorexia | 16 (34.0) | 2 (4.3) | 0 |
Abdominal pain, upper | 12 (25.5) | 4 (8.5) | 0 |
Dysgeusia | 12 (25.5) | 0 | 0 |
Rash | 12 (25.5) | 1 (2.1) | 0 |
Dyspnea | 11 (23.4) | 0 | 0 |
Dehydration | 10 (21.3) | 4 (8.5) | 0 |
Back pain | 9 (19.1) | 2 (4.3) | 0 |
Dizziness | 9 (19.1) | 0 | 0 |
Dry mouth | 8 (17.0) | 0 | 0 |
Urinary tract infection | 8 (17.0) | 0 | 0 |
Constipation | 7 (14.9) | 0 | 0 |
Dyspepsia | 7 (14.9) | 0 | 0 |
Pyrexia | 7 (14.9) | 0 | 0 |
Cough | 6 (12.8) | 1 (2.1) | 0 |
Headache | 6 (12.8) | 0 | 0 |
Abdominal pain | 5 (10.6) | 0 | 0 |
Hypertriglyceridemia | 5 (10.6) | 3 (6.4) | 1 (2.1) |
Myalgia | 5 (10.6) | 0 | 0 |
Tachycardia | 5 (10.6) | 0 | 0 |